Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Bluejay Diagnostics Q2 EPS $(0.10)

Bluejay Diagnostics Q2 EPS $(0.10)

Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(0.10) per share.

byMichael Horton

July 26, 2022

1 minute read

Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(0.10) per share.

What’s Going On With Novavax (NVAX) Stock

By Henry Khederian

June 15, 2:01 PM

Novavax Inc (NASDAQ: NVAX) shares are trading higher by 4.34% to $8.06 Thursday afternoon. The company rescheduled its 2023 Annual Meeting of Stockholders from June 15 to July 11 at 8:30 a.m. ET.

NVAX

Arcturus Therapeutics’ Lung Disease Candidate Triggers Bullish Rating, Analyst Sees Over 200% Upside

By Vandana Singh

December 13, 2:34 PM

Canaccord Genuity has initiated coverage on Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT), a player in the genetic medicine space.

ARCT

Alibaba, Tencent Price Cuts Put Chill On China Tech: Profit Squeeze, Trade Tensions Push Stocks Near Correction Zone

By Benzinga Neuro

May 31, 5:25 AM

Chinese technology stocks are facing a significant downturn, nearing a technical correction due to profit-taking and geopolitical uncertainties.

AMD

JMP Securities Reiterates Market Outperform on CoStar Gr, Maintains $85 Price Target

By Benzinga Newsdesk

February 22, 9:39 AM

JMP Securities analyst Joe Goodwin reiterates CoStar Gr (NASDAQ:CSGP) with a Market Outperform and maintains $85 price target.

CSGP

Bluejay Diagnostics Q2 EPS $(0.10)

Related Posts

What’s Going On With Novavax (NVAX) Stock

Arcturus Therapeutics’ Lung Disease Candidate Triggers Bullish Rating, Analyst Sees Over 200% Upside

Alibaba, Tencent Price Cuts Put Chill On China Tech: Profit Squeeze, Trade Tensions Push Stocks Near Correction Zone

JMP Securities Reiterates Market Outperform on CoStar Gr, Maintains $85 Price Target